Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature



Whelan, Eilbhe, Kalliala, Ilkka, Semertzidou, Anysia ORCID: 0000-0001-7638-8855, Raglan, Olivia, Bowden, Sarah, Kechagias, Konstantinos ORCID: 0000-0001-6681-8479, Markozannes, Georgios ORCID: 0000-0001-8481-579X, Cividini, Sofia ORCID: 0000-0003-2705-9224, McNeish, Iain ORCID: 0000-0002-9387-7586, Marchesi, Julian
et al (show 4 more authors) (2022) Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature. Cancers, 14 (11). p. 2708.

[img] Text
cancers-14-02708.pdf - Published version

Download (790kB) | Preview

Abstract

<jats:p>Several non-genetic factors have been associated with ovarian cancer incidence or mortality. To evaluate the strength and validity of the evidence we conducted an umbrella review of the literature that included systematic reviews/meta-analyses that evaluated the link between non-genetic risk factors and ovarian cancer incidence and mortality. We searched PubMed, EMBASE, Cochrane Database of Systematic Reviews and performed a manual screening of references. Evidence was graded into strong, highly suggestive, suggestive or weak based on statistical significance of the random effects summary estimate and the largest study in a meta-analysis, the number of cases, between-study heterogeneity, 95% prediction intervals, small study effects, and presence of excess significance bias. We identified 212 meta-analyses, investigating 55 non-genetic risk factors for ovarian cancer. Risk factors were grouped in eight broad categories: anthropometric indices, dietary intake, physical activity, pre-existing medical conditions, past drug history, biochemical markers, past gynaecological history and smoking. Of the 174 meta-analyses of cohort studies assessing 44 factors, six associations were graded with strong evidence. Greater height (RR per 10 cm 1.16, 95% confidence interval (CI) 1.11–1.20), body mass index (BMI) (RR ≥ 30 kg/m2 versus normal 1.27, 95% CI 1.17–1.38) and three exposures of varying preparations and usage related to hormone replacement therapy (HRT) use increased the risk of developing ovarian cancer. Use of oral contraceptive pill reduced the risk (RR 0.74, 95% CI 0.69–0.80). Refining the significance of genuine risk factors for the development of ovarian cancer may potentially increase awareness in women at risk, aid prevention and early detection.</jats:p>

Item Type: Article
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Population Health
Depositing User: Symplectic Admin
Date Deposited: 31 May 2022 11:55
Last Modified: 18 Jan 2023 21:00
DOI: 10.3390/cancers14112708
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3155746